Compass Pathways to Announce Second Quarter Financial Results on August 1, 2024

GlobeNewswireJul 24 07:01 ET

Compass a New Outperform at RBC on Optimism for Psychedelic-based Therapies

Seeking AlphaJul 23 15:20 ET

Compass Pathways Initiated at Outperform by RBC Capital

Dow JonesJul 23 06:52 ET

Compass Pathways Price Target Announced at $23.00/Share by RBC Capital

Dow JonesJul 23 06:52 ET · Ratings

RBC Capital Initiates Coverage On Compass Pathways With Outperform Rating, Announces Price Target of $23

BenzingaJul 23 06:42 ET · Ratings

RBC Initiates COMPASS Pathways at Outperform, Speculative Risk With $23 Price Target

MT NewswiresJul 23 06:17 ET · Ratings